Connection

DAVID CORRY to Anti-Bacterial Agents

This is a "connection" page, showing publications DAVID CORRY has written about Anti-Bacterial Agents.
Connection Strength

0.105
  1. Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. Nat Microbiol. 2026 Apr; 11(4):1100-1112.
    View in: PubMed
    Score: 0.105
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.